Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #12,351 to #12,400.
- Cyanotic heart defect interventions (1 revision)
- Cyanotic heart defect other imaging findings (1 revision)
- Cyanotic heart defect secondary prevention (1 revision)
- Cyanotoxin (1 revision)
- Cyanthoate (1 revision)
- Cybernetics (1 revision)
- Cyborg (1 revision)
- Cycasin (1 revision)
- Cyclamate (1 revision)
- Cyclazocine (1 revision)
- Cyclic ADP-ribose (1 revision)
- Cyclic AMP receptors (1 revision)
- Cyclic guanosine monophosphate (1 revision)
- Cyclic nucleotide-gated channel alpha 1 (1 revision)
- Cyclic nucleotide-gated channel alpha 3 (1 revision)
- Cyclic nucleotide-gated channel alpha 4 (1 revision)
- Cyclic nucleotide-gated ion channel (1 revision)
- Cyclic peptide (1 revision)
- Cyclic vomiting syndrome (patient information) (1 revision)
- Cyclic vomiting syndrome diagnostic criteria (1 revision)
- Cyclic vomiting syndrome epidemiology and demographics (1 revision)
- Cyclic vomiting syndrome history and symptoms (1 revision)
- Cyclic vomiting syndrome natural history, complications and prognosis (1 revision)
- Cyclin (1 revision)
- Cyclin-dependent kinase (1 revision)
- Cyclin-dependent kinase 5 (1 revision)
- Cyclin-dependent kinase 9 (1 revision)
- Cyclin A1 (1 revision)
- Cyclin B (1 revision)
- Cyclin D2 (1 revision)
- Cyclin T1 (1 revision)
- Cyclin T2 (1 revision)
- Cyclin dependent kinase like 1 (1 revision)
- Cycling (1 revision)
- Cycloalkane (1 revision)
- Cycloalkyne (1 revision)
- Cyclobenzaprine (patient information) (1 revision)
- Cyclobenzaprine overdose (1 revision)
- Cyclodextrin (1 revision)
- Cyclohexadiene (1 revision)
- Cyclohexane conformation (1 revision)
- Cyclohexanone (1 revision)
- Cyclohexyl nitrite (1 revision)
- Cyclohexylamine (1 revision)
- Cyclopentadienyliron dicarbonyl dimer (1 revision)
- Cyclopentenone prostaglandins (1 revision)
- Cyclopia (1 revision)
- Cycloplegia (1 revision)
- Cyclopropane (1 revision)
- Cyclopropanone (1 revision)